Nerve Transfer to Improve Function in High Level Tetraplegia
Nerve Transfer to Restore Upper Limb Function and Quality of Life in High Tetraplegia
1 other identifier
observational
30
2 countries
10
Brief Summary
The goal of this observational study is to determine if nerve transfer surgeries improve upper extremity function and quality of life in patients with a high level cervical spinal cord injury. Participants will:
- undergo standard of care pre- and post-op testing and study exams
- complete pre- and post-questionnaires
- undergo standard of care nerve transfer surgeries
- follow-up with surgeon at 6/12/18/24/36 and potentially at 48 months
- attend therapy at local therapist for up to 2 years postop.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2024
Longer than P75 for all trials
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 5, 2024
CompletedFirst Submitted
Initial submission to the registry
February 23, 2024
CompletedFirst Posted
Study publicly available on registry
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
March 11, 2026
March 1, 2026
4.1 years
February 23, 2024
March 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Elbow Dynamometry
Change from baseline to 36-48 months post-surgery. Elbow dynamometer measures muscle strength using a handheld portable dynamometer
36-48 months post-surgery
Spinal Cord Independence Measure
Change from baseline to 36-48 months post-surgery. SCIM addresses three specific areas of function in patients with SCI, 1) Self-care (feeding, grooming, bathing, and dressing), 2) respiration and sphincter management, and 3) patient's mobility abilities (transfers from bed and indoors/outdoors). SCIM guide clinicians in determining treatment goals/objectives for SCI patients helping therapists assess measurable outcomes in their functional independence. Scores range from 0-100 with a higher score representing better function.
36-48 months post-surgery
Motor strength in medical research council grade (MRC)
Change in baseline to 36-48 Months post-surgery. The manual muscle testing is a reliable measure of motor strength when assessed by a trained examiner. Scores range from 0-5, with the highest number representing a better score.
36-48 months post-surgery
Electrodiagnosis (Nerve Conduction Study and Electromyography
Change in baseline to 36-48 Months post-surgery. NCS/EMG evaluate neuromuscular health and inform the integrity of lower motor neurons.
36-48 months post-surgery
Secondary Outcomes (5)
Canadian Outcomes Performance Measure (COPM)
36-48 Months post-surgery
Capabilities of Upper Extremity Questionnaire (CUE-Q)
36-48 Months post-surgery
Modified Ashworth Scale (MAS)
36-48 Months post-surgery
Spinal Cord Injury Quality of LIfe Questionnaire
36-48 Months post-surgery
International SCI Pain Basic Dataset (ISCIPBDS)
36-48 Months post-surgery
Eligibility Criteria
Patients with high-level SCI injury (C1-C4) with complete lack of upper extremity function. Occurrence of injury should be greater than 6 months but fewer than 60 months
You may qualify if:
- years of age
- High cervical SCI (motor level C1-C4)
- Motor complete SCI AIS grade A-B
- Plateaued spontaneous recovery for at least 6 months of non-operative therapy
- SCI greater than 6 months and fewer than 60 months since injury
- At least MRC 4/5 donor strength
- Mentally and physically willing and able to comply with evaluations
You may not qualify if:
- Active infection at the operative site or systemic infection
- Any return or ongoing recovery of distal motor function
- Significant joint contractures and/or limitations in passive range of motion in the arm
- Mentally or physically compromised making it impossible to complete study activities
- Immunologically suppressed
- Currently undergoing long-term steroid therapy
- Active malignancy
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michigancollaborator
- The Methodist Hospital Research Institutecollaborator
- University of Pennsylvaniacollaborator
- University of Utahcollaborator
- Washington University School of Medicinelead
- Stanford Universitycollaborator
- University of Miamicollaborator
- Johns Hopkins Universitycollaborator
- University of Albertacollaborator
- Wake Forest University Health Sciencescollaborator
- Department of Defense / Congressionally Mandated Research Program (CDMRP)collaborator
Study Sites (10)
Stanford University
Stanford, California, 94305, United States
University of Miami
Miami, Florida, 33136, United States
Johns Hopkins University
Baltimore, Maryland, 21287, United States
University of Michigan
Ann Arbor, Michigan, 48109, United States
Washington University in St. Louis
St Louis, Missouri, 63110, United States
Wake Forest Medical Center
Winston-Salem, North Carolina, 27157, United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Houston Methodist
Houston, Texas, 77030, United States
University of Utah
Salt Lake City, Utah, 84132, United States
University of Alberta
Edmonton, Alberta, T6G-2E1, Canada
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wilson Z. Ray, MD
Washington University School of Medicine
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD - Principal Investigator
Study Record Dates
First Submitted
February 23, 2024
First Posted
March 1, 2024
Study Start
February 5, 2024
Primary Completion (Estimated)
March 1, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
March 11, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Aggregate data will be shared